-
WTO issues joint indicative list of critical inputs for COVID-19 vaccines
firstwordpharma
July 14, 2021
The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.
-
U.S. says it will push COVID vaccine waivers, but 'may take time'
firstwordpharma
June 11, 2021
US Trade Representative Katherine Tai said the Biden administration is committed to efforts to waive intellectual property rights for COVID-19 vaccines and will raise the issue with the World Trade Organization (WTO)
-
WTO to start vaccine supply negotiations amid clash on patents
firstwordpharma
June 10, 2021
World Trade Organization (WTO) members agreed Wednesday to start formal negotiations on June 17 regarding a plan to boost COVID-19 vaccine supply to developing countries, as reported in Sharenet.
-
COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization
drugs
June 09, 2021
A proposal to ease patents and related protections on COVID-19 vaccines in order to help developing nations fight the pandemic will be considered at a two-day meeting of a World Trade Organization (WTO) panel.
-
IDMA supports patent waiver for vaccines to ramp up production
expresspharma
May 14, 2021
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against reasonable royalties.
-
Over 120 countries back IP rights waiver on Covid-19 vaccines
pharmaceutical-technology
May 08, 2021
In October last year, India and South Africa had floated the proposal to waive IP rights at the World Trade Organization’s (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to waive such protections of the agreement for some ...
-
US supports waiving IP for COVID vaccines
pharmatimes
May 07, 2021
The Biden-Harris Administration has voiced support for waiving intellectual property protections for COVID vaccines, in the hope of ramping up access in low-income countries hit by the virus, marking a u-turn on the US' initial opposition to the move.
-
WTO IP waiver too simplistic: Global vaccine tech-transfer needs other strategies
expresspharma
April 29, 2021
Since October 2020, India and South Africa, joined by two-thirds of the WTO Members (African Group, LDCs and most of the developing world) have been actively pursuing other developed country Members to agree to their request to waive global ...
-
LDCs support India, South Africa’s request to waive COVID vaccine-related IPR
expresspharma
April 15, 2021
The 46-member grouping of the Least Developed Countries (LDC) has said it supports a request made by India and South Africa to the WTO to temporarily suspend intellectual property rights for the COVID-19 vaccines to increase their access in these ...
-
Commerce Secretary reaffirms India’s commitment to ensuring equitable and affordable access to vaccines and COVID-treatments for all
expresspharma
January 08, 2021
As India’s 7th Trade Policy Review at the WTO begins, members applauded India’s leadership role in the global efforts against the COVID-19 pandemic, acknowledging India’s position as the ‘pharmacy of the world’.